Option chain shows key data for Pharmadrug's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Pharmadrug.

Pharmadrug (OTC:LMLLF) Stock, Option Chain

Pharmadrug Inc is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and naturally derived approved drugs. The Company's operations comprise of the corporate division in Canada. Geographically, it operates in Germany and Canada.

Cannabis

News

Penny Stocks

Psychedelics

Sector ETFs

Financing

Contracts

Legal

Management

Global

Markets

ETFs

AGNPF

AWKNF

CMND

CYBN

FLHLF

IWINF

LMLLF

PHRRF

PSIL

PSYK

SPRC

Two Bills Approved By Hawaii Senators With Governor&#39;s Endorsement

Hawaii Senate Ways and Means Committee approved a pair of bills aiming to promote and investigate the therapeutic potential of MDMA and psilocybin as an alternative to treat mental health conditions.

Psyched: Hawaii And Minnesota&#39;s Bills, Studying 2C-B Vs. Psilocybin, Filament CEO, Plus Brock Pierce And Jeremy Gardner Discuss The Industry&#39;s Future And More

Specialty R&amp;D psychedelics company PharmaDrug Inc. (OTCQB: LMLLF) has inked a research collaboration agreement with PharmaTher Holdings Ltd. (OTCMKTS: PHRRF) to evaluate the delivery of DMT through PharmaTher&#39;s microneedle patch technology.

Development Of DMT Transdermal Patch With Eye Disease Treatment In Mind

KHIRON LIFE SCIENCES CORP by Khiron Life Sciences Corp.

KHRNF

TSXV:KHRN

CSE:PHRX

Khiron Life Sciences Corp. (TSXV:KHRN) (OTCQX: KHRNF) (Frankfurt:A2JMZC) has completed the acquisition of Pharmadrug Production GmbH from Pharmadrug Inc. (OTCQB: LMLLF) (CSE:PHRX).

Khiron Completes Acquisition Of Pharmadrug Production, Expanding Its Presence In Europe

Pharmadrug Inc

Health Care

Press Releases

PharmaTher's Sairiyo Therapeutics Completes Clinical and Regulatory Package for Phase 1 Study of Patented Reformulated Cepharanthine

PharmaTher's Sairiyo Therapeutics Submits Clinical Trial Application for Phase 1 Study of Patented Reformulated Cepharanthine

Specialty Pharma Company Moving Higher After Signing LOI for Pharmaceutical-Grade Cocaine

PharmaTher's Sairiyo Therapeutics Receives Approval to Initiate a Phase 1 Human Clinical Trial of PD-001 (Reformulated Cepharanthine)

Analyst Ratings

General

PharmaTher's Sairiyo Therapeutics Announces Independent Screening Identifying Cepharanthine's Potential to Bind to Monkeypox (Mpox) Proteins

CSE:PHRM

Pharmadrug

Comments

Pharmadrug

Pharmadrug (LMLLF) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga